These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 27897153)

  • 1. Isoflurane Promotes Non-Small Cell Lung Cancer Malignancy by Activating the Akt-Mammalian Target of Rapamycin (mTOR) Signaling Pathway.
    Zhang W; Shao X
    Med Sci Monit; 2016 Nov; 22():4644-4650. PubMed ID: 27897153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiproliferative Activity of Carnosic Acid is Mediated via Inhibition of Cell Migration and Invasion, and Suppression of Phosphatidylinositol 3-Kinases (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Signaling Pathway.
    Zhao L; Zhang J; Fan Y; Li Y
    Med Sci Monit; 2019 Oct; 25():7864-7871. PubMed ID: 31631173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FAM83D promotes epithelial-mesenchymal transition, invasion and cisplatin resistance through regulating the AKT/mTOR pathway in non-small-cell lung cancer.
    Yin C; Lin X; Wang Y; Liu X; Xiao Y; Liu J; Snijders AM; Wei G; Mao JH; Zhang P
    Cell Oncol (Dordr); 2020 Jun; 43(3):395-407. PubMed ID: 32006253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling.
    Tang Y; Xiao G; Chen Y; Deng Y
    Anticancer Drugs; 2018 Sep; 29(8):725-735. PubMed ID: 29916897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-treatment with BEZ235 enhances chemosensitivity of A549/DDP cells to cisplatin via inhibition of PI3K/Akt/mTOR signaling and downregulation of ERCC1 expression.
    Xia A; Li H; Li R; Lu L; Wu X
    Oncol Rep; 2018 Oct; 40(4):2353-2362. PubMed ID: 30066933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FKBP4 Accelerates Malignant Progression of Non-Small-Cell Lung Cancer by Activating the Akt/mTOR Signaling Pathway.
    Meng W; Meng J; Jiang H; Feng X; Wei D; Ding Q
    Anal Cell Pathol (Amst); 2020; 2020():6021602. PubMed ID: 33354489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SSPH I, A Novel Anti-cancer Saponin, Inhibits EMT and Invasion and Migration of NSCLC by Suppressing MAPK/ERK1/2 and PI3K/AKT/ mTOR Signaling Pathways.
    Zhou J; Luo J; Gan R; Zhi L; Zhou H; Lv M; Huang Y; Liang G
    Recent Pat Anticancer Drug Discov; 2024; 19(4):543-555. PubMed ID: 38305308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin inhibits migration and invasion of non-small cell lung cancer cells through up-regulation of miR-206 and suppression of PI3K/AKT/mTOR signaling pathway.
    Wang N; Feng T; Liu X; Liu Q
    Acta Pharm; 2020 Sep; 70(3):399-409. PubMed ID: 32074070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxysafflor yellow A inhibited lipopolysaccharide-induced non-small cell lung cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT/mTOR and ERK/MAPK signaling pathways.
    Jiang M; Zhou LY; Xu N; An Q
    Thorac Cancer; 2019 Jun; 10(6):1319-1333. PubMed ID: 31055884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baicalin, a Chinese Herbal Medicine, Inhibits the Proliferation and Migration of Human Non-Small Cell Lung Carcinoma (NSCLC) Cells, A549 and H1299, by Activating the SIRT1/AMPK Signaling Pathway.
    You J; Cheng J; Yu B; Duan C; Peng J
    Med Sci Monit; 2018 Apr; 24():2126-2133. PubMed ID: 29632297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphine promotes non-small cell lung cancer progression by downregulating E-cadherin via the PI3K/AKT/mTOR pathway.
    Gu F; Zhou Y; Tian L; Chen J; Zhang C; Huang Z; Yu W; Xie K
    Sci Rep; 2024 Sep; 14(1):21130. PubMed ID: 39256509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways.
    Han S; Khuri FR; Roman J
    Cancer Res; 2006 Jan; 66(1):315-23. PubMed ID: 16397245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OTUB2 stabilizes U2AF2 to promote the Warburg effect and tumorigenesis via the AKT/mTOR signaling pathway in non-small cell lung cancer.
    Li J; Cheng D; Zhu M; Yu H; Pan Z; Liu L; Geng Q; Pan H; Yan M; Yao M
    Theranostics; 2019; 9(1):179-195. PubMed ID: 30662561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Musashi1 Promotes Non-Small Cell Lung Carcinoma Malignancy and Chemoresistance via Activating the Akt Signaling Pathway.
    Lang Y; Kong X; He C; Wang F; Liu B; Zhang S; Ning J; Zhu K; Xu S
    Cell Physiol Biochem; 2017; 44(2):455-466. PubMed ID: 29141252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDKL3 Promotes Non-small Cell Lung Cancer by Suppressing Autophagy Via Activation of PI3K/Akt/mTOR Pathway.
    Li R; Chai L; Lei L; Guo R; Wen X
    Mol Biotechnol; 2023 Sep; 65(9):1421-1431. PubMed ID: 36630073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rosemary extract reduces Akt/mTOR/p70S6K activation and inhibits proliferation and survival of A549 human lung cancer cells.
    Moore J; Megaly M; MacNeil AJ; Klentrou P; Tsiani E
    Biomed Pharmacother; 2016 Oct; 83():725-732. PubMed ID: 27470574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Luteoloside induces G
    Zhou M; Shen S; Zhao X; Gong X
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):263-269. PubMed ID: 29024631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoflurane promotes proliferation of squamous cervical cancer cells through mTOR-histone deacetylase 6 pathway.
    Zhang W; Xue F; Xie S; Chen C; Li J; Zhu X
    Mol Cell Biochem; 2021 Jan; 476(1):45-55. PubMed ID: 32833118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTPRH promotes the progression of non-small cell lung cancer via glycolysis mediated by the PI3K/AKT/mTOR signaling pathway.
    Wang S; Cheng Z; Cui Y; Xu S; Luan Q; Jing S; Du B; Li X; Li Y
    J Transl Med; 2023 Nov; 21(1):819. PubMed ID: 37974250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.